Global Monoclonal Antibodies Market Research Report 2019


    Table of Contents

      Executive Summary

        1 Monoclonal Antibodies Market Overview

        • 1.1 Product Overview and Scope of Monoclonal Antibodies
        • 1.2 Monoclonal Antibodies Segment by Type
          • 1.2.1 Global Monoclonal Antibodies Production Growth Rate Comparison by Type (2014-2025)
          • 1.2.2 Cancer
          • 1.2.3 Autoimmune Diseases
          • 1.2.4 Infection
          • 1.2.5 Hematological Diseases
          • 1.2.6 Others
        • 1.3 Monoclonal Antibodies Segment by Application
          • 1.3.1 Monoclonal Antibodies Consumption Comparison by Application (2014-2025)
          • 1.3.2 Oncology
          • 1.3.3 Autoimmune and inflammatory diseases
          • 1.3.4 Respiratory diseases
          • 1.3.5 Ophthalmology
        • 1.4 Global Monoclonal Antibodies Market by Region
          • 1.4.1 Global Monoclonal Antibodies Market Size Region
          • 1.4.2 North America Status and Prospect (2014-2025)
          • 1.4.3 Europe Status and Prospect (2014-2025)
          • 1.4.4 China Status and Prospect (2014-2025)
          • 1.4.5 Japan Status and Prospect (2014-2025)
        • 1.5 Global Monoclonal Antibodies Market Size
          • 1.5.1 Global Monoclonal Antibodies Revenue (2014-2025)
          • 1.5.2 Global Monoclonal Antibodies Production (2014-2025)

        2 Global Monoclonal Antibodies Market Competition by Manufacturers

        • 2.1 Global Monoclonal Antibodies Production Market Share by Manufacturers (2014-2019)
        • 2.2 Global Monoclonal Antibodies Revenue Share by Manufacturers (2014-2019)
        • 2.3 Global Monoclonal Antibodies Average Price by Manufacturers (2014-2019)
        • 2.4 Manufacturers Monoclonal Antibodies Production Sites, Area Served, Product Types
        • 2.5 Monoclonal Antibodies Market Competitive Situation and Trends
          • 2.5.1 Monoclonal Antibodies Market Concentration Rate
          • 2.5.2 Monoclonal Antibodies Market Share of Top 3 and Top 5 Manufacturers
          • 2.5.3 Mergers & Acquisitions, Expansion

        3 Global Monoclonal Antibodies Production Market Share by Regions

        • 3.1 Global Monoclonal Antibodies Production Market Share by Regions
        • 3.2 Global Monoclonal Antibodies Revenue Market Share by Regions (2014-2019)
        • 3.3 Global Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.4 North America Monoclonal Antibodies Production
          • 3.4.1 North America Monoclonal Antibodies Production Growth Rate (2014-2019)
          • 3.4.2 North America Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.5 Europe Monoclonal Antibodies Production
          • 3.5.1 Europe Monoclonal Antibodies Production Growth Rate (2014-2019)
          • 3.5.2 Europe Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.6 China Monoclonal Antibodies Production (2014-2019)
          • 3.6.1 China Monoclonal Antibodies Production Growth Rate (2014-2019)
          • 3.6.2 China Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
        • 3.7 Japan Monoclonal Antibodies Production (2014-2019)
          • 3.7.1 Japan Monoclonal Antibodies Production Growth Rate (2014-2019)
          • 3.7.2 Japan Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)

        4 Global Monoclonal Antibodies Consumption by Regions

        • 4.1 Global Monoclonal Antibodies Consumption by Regions
        • 4.2 North America Monoclonal Antibodies Consumption (2014-2019)
        • 4.3 Europe Monoclonal Antibodies Consumption (2014-2019)
        • 4.4 China Monoclonal Antibodies Consumption (2014-2019)
        • 4.5 Japan Monoclonal Antibodies Consumption (2014-2019)

        5 Global Monoclonal Antibodies Production, Revenue, Price Trend by Type

        • 5.1 Global Monoclonal Antibodies Production Market Share by Type (2014-2019)
        • 5.2 Global Monoclonal Antibodies Revenue Market Share by Type (2014-2019)
        • 5.3 Global Monoclonal Antibodies Price by Type (2014-2019)
        • 5.4 Global Monoclonal Antibodies Production Growth by Type (2014-2019)

        6 Global Monoclonal Antibodies Market Analysis by Applications

        • 6.1 Global Monoclonal Antibodies Consumption Market Share by Application (2014-2019)
        • 6.2 Global Monoclonal Antibodies Consumption Growth Rate by Application (2014-2019)

        7 Company Profiles and Key Figures in Monoclonal Antibodies Business

        • 7.1 AbbVie
          • 7.1.1 AbbVie Monoclonal Antibodies Production Sites and Area Served
          • 7.1.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.1.3 AbbVie Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.1.4 Main Business and Markets Served
        • 7.2 Roche
          • 7.2.1 Roche Monoclonal Antibodies Production Sites and Area Served
          • 7.2.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.2.3 Roche Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.2.4 Main Business and Markets Served
        • 7.3 Johnson & Johnson
          • 7.3.1 Johnson & Johnson Monoclonal Antibodies Production Sites and Area Served
          • 7.3.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.3.3 Johnson & Johnson Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.3.4 Main Business and Markets Served
        • 7.4 Amgen
          • 7.4.1 Amgen Monoclonal Antibodies Production Sites and Area Served
          • 7.4.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.4.3 Amgen Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.4.4 Main Business and Markets Served
        • 7.5 Merck
          • 7.5.1 Merck Monoclonal Antibodies Production Sites and Area Served
          • 7.5.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.5.3 Merck Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.5.4 Main Business and Markets Served
        • 7.6 BMS
          • 7.6.1 BMS Monoclonal Antibodies Production Sites and Area Served
          • 7.6.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.6.3 BMS Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.6.4 Main Business and Markets Served
        • 7.7 Eli Lilly
          • 7.7.1 Eli Lilly Monoclonal Antibodies Production Sites and Area Served
          • 7.7.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.7.3 Eli Lilly Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.7.4 Main Business and Markets Served
        • 7.8 Formation Biologics
          • 7.8.1 Formation Biologics Monoclonal Antibodies Production Sites and Area Served
          • 7.8.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.8.3 Formation Biologics Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.8.4 Main Business and Markets Served
        • 7.9 Genmab
          • 7.9.1 Genmab Monoclonal Antibodies Production Sites and Area Served
          • 7.9.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.9.3 Genmab Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.9.4 Main Business and Markets Served
        • 7.10 GlaxoSmithKline
          • 7.10.1 GlaxoSmithKline Monoclonal Antibodies Production Sites and Area Served
          • 7.10.2 Monoclonal Antibodies Product Introduction, Application and Specification
          • 7.10.3 GlaxoSmithKline Monoclonal Antibodies Production, Revenue, Price and Gross Margin (2014-2019)
          • 7.10.4 Main Business and Markets Served
        • 7.11 Human Genome Sciences
        • 7.12 mmunogen
        • 7.13 MedImmune
        • 7.14 Novartis
        • 7.15 Pfizer
        • 7.16 Seattle Genetics
        • 7.17 Stemcentrx
        • 7.18 Synthon Biopharmaceuticals
        • 7.19 Takeda
        • 7.20 Teva

        8 Monoclonal Antibodies Manufacturing Cost Analysis

        • 8.1 Monoclonal Antibodies Key Raw Materials Analysis
          • 8.1.1 Key Raw Materials
          • 8.1.2 Price Trend of Key Raw Materials
          • 8.1.3 Key Suppliers of Raw Materials
        • 8.2 Proportion of Manufacturing Cost Structure
        • 8.3 Manufacturing Process Analysis of Monoclonal Antibodies
        • 8.4 Monoclonal Antibodies Industrial Chain Analysis

        9 Marketing Channel, Distributors and Customers

        • 9.1 Marketing Channel
          • 9.1.1 Direct Marketing
          • 9.1.2 Indirect Marketing
        • 9.2 Monoclonal Antibodies Distributors List
        • 9.3 Monoclonal Antibodies Customers

        10 Market Dynamics

        • 10.1 Market Trends
        • 10.2 Opportunities
        • 10.3 Market Drivers
        • 10.4 Challenges
        • 10.5 Influence Factors

        11 Global Monoclonal Antibodies Market Forecast

        • 11.1 Global Monoclonal Antibodies Production, Revenue Forecast
          • 11.1.1 Global Monoclonal Antibodies Production Growth Rate Forecast (2019-2025)
          • 11.1.2 Global Monoclonal Antibodies Revenue and Growth Rate Forecast (2019-2025)
          • 11.1.3 Global Monoclonal Antibodies Price and Trend Forecast (2019-2025)
        • 11.2 Global Monoclonal Antibodies Production Forecast by Regions (2019-2025)
          • 11.2.1 North America Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
          • 11.2.2 Europe Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
          • 11.2.3 China Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
          • 11.2.4 Japan Monoclonal Antibodies Production, Revenue Forecast (2019-2025)
        • 11.3 Global Monoclonal Antibodies Consumption Forecast by Regions (2019-2025)
          • 11.3.1 North America Monoclonal Antibodies Consumption Forecast (2019-2025)
          • 11.3.2 Europe Monoclonal Antibodies Consumption Forecast (2019-2025)
          • 11.3.3 China Monoclonal Antibodies Consumption Forecast (2019-2025)
          • 11.3.4 Japan Monoclonal Antibodies Consumption Forecast (2019-2025)
        • 11.4 Global Monoclonal Antibodies Production, Revenue and Price Forecast by Type (2019-2025)
        • 11.5 Global Monoclonal Antibodies Consumption Forecast by Application (2019-2025)

        12 Research Findings and Conclusion

          13 Methodology and Data Source

          • 13.1 Methodology/Research Approach
            • 13.1.1 Research Programs/Design
            • 13.1.2 Market Size Estimation
            • 13.1.3 Market Breakdown and Data Triangulation
          • 13.2 Data Source
            • 13.2.1 Secondary Sources
            • 13.2.2 Primary Sources
          • 13.3 Author List

          Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
          This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.

          The global Monoclonal Antibodies market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
          This report focuses on Monoclonal Antibodies volume and value at global level, regional level and company level. From a global perspective, this report represents overall Monoclonal Antibodies market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
          At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

          The following manufacturers are covered:
          AbbVie
          Roche
          Johnson & Johnson
          Amgen
          Merck
          BMS
          Eli Lilly
          Formation Biologics
          Genmab
          GlaxoSmithKline
          Human Genome Sciences
          mmunogen
          MedImmune
          Novartis
          Pfizer
          Seattle Genetics
          Stemcentrx
          Synthon Biopharmaceuticals
          Takeda
          Teva

          Segment by Regions
          North America
          Europe
          China
          Japan

          Segment by Type
          Cancer
          Autoimmune Diseases
          Infection
          Hematological Diseases
          Others

          Segment by Application
          Oncology
          Autoimmune and inflammatory diseases
          Respiratory diseases
          Ophthalmology



          Summary:
          Monoclonal Antibodies Market Research Report is Monoclonal Antibodies Market Report. Get Monoclonal Antibodies market research reports for Market Research, Analysis, Trends & Statistics. Latest Industry findings, analysis and Market Report on Monoclonal Antibodies . Monoclonal Antibodies Market Report is a syndicated market report to understand, Market Demand, Growth, trends analysis and Factor Influencing market in upcoming years.



          REPORT YOU MIGHT BE INTERESTED